Evidence map›Paper›PMID 30273093›Full record

ReviewSmall GTPases2020

Rab GTPases take centre stage in understanding

Kuldeep Verma, Vijay Kumar Srivastava, Sunando Datta

Open access · bronzeAbstract readReview
In one paragraph

Review in Small GTPases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Theoretical Study of Sphingomyelinases fromPathogens (Basel, Switzerland) · 2025
    Article
  3. International journal of molecular sciences · 2024
    Article
  4. Endocytosis in anaerobic parasitic protists.Memorias do Instituto Oswaldo Cruz · 2024
    Review
  5. Article
  6. Article
  7. The Gal/GalNac lectin as a possible acetylcholine receptor inFrontiers in cellular and infection microbiology · 2023
    Article
  8. Article
  9. Article
  10. Molecular interplays of theFrontiers in cellular and infection microbiology · 2022
    Review
  11. Article
  12. Article
  13. Probing the Peculiarity ofBioMed research international · 2021
    Article
  14. Article
  15. Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.Frontiers in cellular and infection microbiology · 2020
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kuldeep VermaInstitute of Science, Nirma University , Ahmedabad, Gujarat, India.ORCID 0000-0002-8912-3781
Vijay Kumar SrivastavaAmity Institute of Biotechnology, Amity University Jaipur , Jaipur, Rajasthan, India.ORCID 0000-0003-3395-2051
Sunando DattaDepartment of Biological Science, Indian Institute of Science Education and Research Bhopal , Bhauri, India.ORCID 0000-0002-1417-0276
Indian Institute of Science Education and Research, Bhopal · INNirma University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rab GTPases constitute the largest subgroup in the Ras superfamily of GTPases. It is well established that different Rab GTPases are localized in discrete subcellular localization and regulate the membrane trafficking in nearly all eukaryotic cells. Rab GTPase diversity is often regarded as an expression of vesicular trafficking complexity. The pathogenic amoeba

Indexed as

AnimalsEntamoeba histolyticaHumansrab GTP-Binding Proteinsrab GTP-Binding ProteinsEntamoeba histolytica; Rab GTPasemembrane traffickingphagocytosistissue invasion

Identifiers

PMID30273093
PMCPMC7549625
OpenAlexW2894833352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.